Fibrosis Completed Phase 3 Trials for Ketorolac (DB00465)

Also known as: Fibrosis (morphologic abnormality) / Fibrosis (qualifier value) / Fibrosis NOS

IndicationStatusPhase
DBCOND0012375 (Fibrosis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00707421Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical OutcomesPrevention